The PE Ratio as of November 2024 (TTM) for Fortress Biotech, Inc. (FBIO) is -0.54

According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.54. This represents a change of -17.40% compared to the average of -0.65 of the last 4 quarters.

Fortress Biotech, Inc. (FBIO) Historical PE Ratio (quarterly & annually)

How has FBIO PE Ratio performed in the past?

The mean historical PE Ratio of Fortress Biotech, Inc. over the last ten years is -1.83. The current -0.54 PE Ratio has changed 2.84% with respect to the historical average. Over the past ten years (40 quarters), FBIO's PE Ratio was at its highest in in the March 2019 quarter at 21.63. The PE Ratio was at its lowest in in the June 2021 quarter at -20.44.

Fortress Biotech, Inc. (FBIO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Fortress Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fortress Biotech, Inc. (FBIO) Average PE Ratio

How has FBIO PE Ratio performed in the past?

The current PE Ratio of Fortress Biotech, Inc. (FBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fortress Biotech, Inc. (FBIO) PE Ratio vs. Peers

How is FBIO’s PE Ratio compared to its peers?

Fortress Biotech, Inc.’s PE Ratio is less than Mustang Bio, Inc. (-0.32), greater than Achilles Therapeutics plc (-0.64), less than Aptose Biosciences Inc. (-0.10), greater than Fortress Biotech, Inc. (-0.62), greater than Checkpoint Therapeutics, Inc. (-3.48), less than Avenue Therapeutics, Inc. (-0.23), greater than Pieris Pharmaceuticals, Inc. (-1.39), greater than Aileron Therapeutics, Inc. (-1.83), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Eyenovia, Inc. (-0.20), less than Cognition Therapeutics, Inc. (-0.50), less than TransCode Therapeutics, Inc. (-0.38), greater than Kodiak Sciences Inc. (-1.70), greater than XOMA Corporation (-11.81), greater than ZIVO Bioscience, Inc. (-5.20), greater than Lumos Pharma, Inc. (-1.03), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Athira Pharma, Inc. (-0.23), less than ACADIA Pharmaceuticals Inc. (21.14), greater than Cabaletta Bio, Inc. (-0.88),

Build a custom stock screener for Fortress Biotech, Inc. (FBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fortress Biotech, Inc. (FBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.